GOLDMAN SACHS GROUP INC - OREXIGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 53 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 17.08 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$37,000
-26.0%
17,336
-0.4%
0.00%–
Q2 2017$50,000
-59.3%
17,411
-51.4%
0.00%–
Q1 2017$123,000
+35.2%
35,791
-31.7%
0.00%–
Q4 2016$91,000
-19.5%
52,385
+53.8%
0.00%–
Q3 2016$113,000–34,057–0.00%–
 Download
Other shareholders

There were no reported owners of OREXIGEN THERAPEUTICS INC in Q3 2016.

NameSharesValueWeighting ↓
View complete list of OREXIGEN THERAPEUTICS INC shareholders